Next Science Limited (NXS.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
As of 11:15AM AEDT. Market open.
| Previous close | 0.6700 |
| Open | 0.6800 |
| Bid | 0.6550 x 853200 |
| Ask | 0.6600 x 1877300 |
| Day's range | 0.6550 - 0.6800 |
| 52-week range | 0.5900 - 1.3300 |
| Volume | |
| Avg. volume | 72,709 |
| Market cap | 142.835M |
| Beta (5Y monthly) | 0.73 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0680 |
| Earnings date | 21 Feb 2023 - 27 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.89 |
- Simply Wall St.
Investors in Next Science (ASX:NXS) have unfortunately lost 78% over the last three years
As every investor would know, not every swing hits the sweet spot. But you want to avoid the really big losses like the...
- Business Wire
New Study Finds XPERIENCE™ No Rinse Solution Has Persistent Efficacy Against Both Planktonic Bacteria and Bacterial Biofilms
JACKSONVILLE, Fla., May 10, 2022--Next Science Limited (ASX:NXS) (Next Science / the Company) is pleased to report that XPERIENCE™ No Rinse Solution has been shown to have persistent efficacy against both planktonic bacteria and bacterial biofilms in a new study published in The Journal of Arthroplasty. The study, "A Novel Irrigant to Eliminate Planktonic Bacteria and Eradicate Biofilm Superstructure With Persistent Effect During Total Hip Arthroplasty," also found that XPERIENCE produced minima
- Simply Wall St.
What Is The Ownership Structure Like For Next Science Limited (ASX:NXS)?
Every investor in Next Science Limited ( ASX:NXS ) should be aware of the most powerful shareholder groups. Insiders...
© 2023 Yahoo. All rights reserved.
